USPTO Files Opening Brief in Tafas v. Dudas Appeal
Patent Docs: By Donald Zuhn and Benjamin Huber — Last Friday, the U.S. Patent and Trademark Office and USPTO Director Jon Dudas filed their opening brief in the Tafas v. Dudas appeal. As we previously reported, the Patent Office and Director Dudas had until July 18th (i.e., sixty days from the May 19th docketing date) to serve and file their opening brief. The Appellees — Dr. Triantafyllos Tafas and SmithKline Beecham Corp., SmithKline Beecham PLC, and Glaxo Group Ltd. (GSK) — now have until August 27th, absent any extensions, to file their brief. By now, many patent practitioners are probably quite familiar…